GSK says senior executives appear to have broken Chinese law
LONDON (Reuters) - GlaxoSmithKline (GSK.L), facing a major bribery scandal in China, said on Monday that some of its executives in the country appeared to have broken the law.
"Certain senior executives of GSK China, who know our systems well, appear to have acted outside of our processes and controls which breaches Chinese law," the British drugmaker's head of emerging markets, Abbas Hussain, said in a statement.
Hussain, who was sent to China last week to lead GSK's response to the crisis, held a meeting with the Ministry of Public Security at which he also promised to review GSK's business model, leading to price reductions in the country.
(Reporting by Ben Hirschler, Editing by Brenda Goh)
- Ukraine says Russian tanks flatten town; EU to threaten more sanctions |
- Seven NATO allies to create new rapid reaction force-report
- F-16s dispatched for unresponsive pilot of small plane near D.C.
- Islamic State militants behead captive Lebanese soldier: video
- Car tied to suspected threat against Obama found in Connecticut